| Financial Year |
March 31 2023 |
| Monetary Funds |
136,294,601.72 |
| Held-for-trading Financial Assets |
290,727,123.39 |
| Notes Receivable |
4,330,119.02 |
| Accounts Receivable |
677,477,272.78 |
| Advances to Suppliers |
111,650,910.06 |
| Other Receivables |
12,701,764.28 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
211,910,266.75 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
66,644,400.00 |
| Other Current Assets |
8,575,730.83 |
| Total Current Assets |
1,650,133,570.64 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
131,625,618.33 |
| Long-term Equity Investment |
37,694,391.44 |
| Investment Properties |
-- |
| Fixed Assetes |
92,913,783.45 |
| Under-construction Projects |
99,994,704.20 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
299,598,355.28 |
| R&D expenses |
-- |
| Goodwill |
2,970,092.93 |
| Long-Term Deferred and Prepaid Expenses |
4,108,340.76 |
| Deferred Income Tax Assets |
40,597,532.59 |
| Other Non-Current Assets |
104,818,553.38 |
| Sub-Total of Non-Current Assets |
814,321,372.36 |
| Total Assets |
2,464,454,943.00 |
| Short-Term Loans |
9,500,000.00 |
| Trading Financial liabilities |
-- |
| Notes Payable |
29,473,663.05 |
| Accounts Payable |
387,178,195.03 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
11,989,587.24 |
| Taxes Payable |
59,979,891.01 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
5,135,570.74 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
-- |
| Other Current Liabilities |
28,641,381.97 |
| Sub-Total of Current Liabilities |
871,025,666.39 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
20,292,267.43 |
| Deferred Income Tax Liabilities |
735,471.15 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
24,678,238.58 |
| Total Liabilities |
895,703,904.97 |
| Paid-In Capital(Or Share Stock) |
408,763,660.00 |
| Capital Surplus |
512,182,844.93 |
| Surplus Reserve |
69,888,060.10 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
445,252,789.03 |
| Minority Stockholder's Interest |
132,663,683.97 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,436,087,354.06 |
| Owner's Equity（Stockholder's Equity） |
1,568,751,038.03 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
2,464,454,943.00 |
